NASDAQ
Adverum Biotechnologies, Inc. (ADVM) has a revenue compound annual growth rate of 31.95% over 5 years and 5.75% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.